Alert: Legal Psychedelics Could Be the Next Cannabis Stocks!

Psychedelics have been legalized or decriminalized in two states this week. Canadian stocks like Mind Medicine (MindMed) Inc. (OTC:MMED) could be at the forefront.

| More on:
edit Jars of marijuana

Image source: Getty Images

While the world waits with bated breath for the results of the U.S. presidential election, voters in key U.S. states have already made a historic decision. Two key states have decriminalized the use of psychedelics for medical purposes. This could be an (extremely) early sign that psychedelics could become legalized on par with marijuana soon.

Here’s why investors should follow these latest developments closely.

Background on psychedelic drugs

Johns Hopkins University—the U.S.’s oldest research university—launched a dedicated center for psychedelic studies. While it’s still early, researchers believe the substance could help treat certain psychological conditions such as depression and post-traumatic stress disorder (PTSD). 

An estimated 17.3 million people suffer from depression in the United States alone, which goes to show how critical this research is. 

The U.S. election

Yesterday’s election for the Presidential race is still too close to call. However, Americans were voting for a lot more than just the White House. Senate seats, for example, were up for grabs as were key state legislation measures. 

Yesterday, Oregon voters passed Measure 109 – a move that could allow medical professionals and researchers to study the benefits of psychedelic drugs such as psilocybin. Popular known as magic mushrooms, these drugs are prohibited in nearly every part of the world. However, interest in their medical benefits has been growing in recent years. 

Similarly, voters in Washington D.C passed Initiative 81 yesterday to decriminalize the use of psychedelic drugs. Yet another indication that public perception about magic mushrooms is shifting. If their medical benefits are proven, more states and perhaps other countries could follow this lead. 

Some industry experts believe the market could be as big as US$6.8 billion (C$8.9 billion) by 2027 if the wave of legalization and medical use continues. That’s a big market, but not nearly as big as the global cannabis industry. Nevertheless, since investors have overlooked this space and there’s only a handful of players, the opportunities seem attractive. 

Canadian psychedelic stocks

A few medical startups have listed on Canadian stock exchanges in recent years. The most noteworthy, perhaps, is Mind Medicine (MindMed) Inc. (OTC:MMED), which is listed on the NEO exchange and is available over the counter. 

Cannabis titan Bruce Linton, the founder and former CEO of Canopy Growth, is a MindMed director. The company is also backed by Shark Tank’s Kevin O’Leary, who told Fast Company, “this could save lives, cure depression, help alcoholism, get people off opioids—why wouldn’t I want to be invested?”  

MindMed stock is up 5.5% today on news of Oregon and D.C.’s ballot initiatives. The company is worth $334 million, but could surge a lot higher if the trend continues and more investors get involved in this space. 

Bottom line

Decisive votes in two American states have paved the way for the legalization of psychedelic drugs. This breakthrough could add tremendous value to Canadian startups like MindMed that are working on developing these substances. 

While the market won’t be as big as legal cannabis, it will certainly create extensive shareholder value for early investors. Keep an eye on this stock as the industry matures over the next few years. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned.

More on Investing

A person builds a rock tower on a beach.
Dividend Stocks

CPP Pension: Boost Your Payouts by $5,232 per Year

You can raise your after-tax CPP by making RRSP contributions. Alimentation Couche-Tard (TSX:ATD) is a good RRSP stock.

Read more »

Overhead shot of young adults using technology at a table
Tech Stocks

1 Stock That’s Just as Hot as Tesla Stock  (Without All the Hype)

Sure, Tesla stock (NASDAQ:TSLA) has the headlines, but this other stock has far more growth, with even more on the…

Read more »

A close up image of Canadian $20 Dollar bills
Dividend Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

Here are three no-brainer stocks that are suitable for anyone getting started on their investing journey.

Read more »

thinking
Bank Stocks

Could Royal Bank Stock Reach $200?

Growing rate cut hopes and improving analysts’ expectations from Royal Bank’s financial results could help its stock maintain strong upward…

Read more »

A plant grows from coins.
Investing

3 Growth Stocks to Buy With $3,000 for the Next 3 Years

These growth stocks have the potential to deliver above-average returns and compound investors’ wealth.

Read more »

Young woman sat at laptop by a window
Investing

Here’s Why I Think Restaurant Brands Is 1 of the Best Bets on the TSX Today 

Here's why Restaurant Brands (TSX:QSR) could be one of the best stocks to buy for long-term upside in this current…

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Dividend Stocks

This 5% Dividend Stock Pays Cash Every Month

This monthly dividend stock offers cash every month, but also returns that continue to climb higher from being in a…

Read more »

growing plant shoots on stacked coins
Dividend Stocks

3 Top Dividend Stocks That Keep Raising Their Payouts

These three TSX stocks are ideal buy as they consistently raise their payouts, depicting their healthy financials.

Read more »